Market by Gender, Indications, Treatment Type, Sales Channel, and Regional Outlook | Forecast 2021-2028
Alopecia is an autoimmune
disorder that causes extreme hair loss in an individual. A person affected by alopecia
may experience hair fall in the form of a patch or have a declining hairline.
It is a medical condition leading to partial or complete loss of hair,
especially on the scalp, either in patches, on the entire head, or over the
entire body. It can affect both adults as well as children.
As per Triton Market Research, the global market for hair loss treatment was valued at $2413.86 million in 2020 and is expected to reach $3768.97 million by 2028, growing at a CAGR of 5.07% during the forecast period.
Triton’s report on the hair
loss treatment market provides an in-depth insight into the industry. The
detailed analysis of the market includes key insights, Porter’s five forces
analysis, market attractiveness index, vendor scorecard, key strategies, and
the impact of COVID-19 on the hair loss treatment market.
The market is driven by
several factors such as the rise in cases of autoimmune disease, high
consumption of alcohol & tobacco, unhealthy dietary habits, stress, and
changing lifestyles. The prevalence of chronic diseases is increasing globally.
According to the National Stem Cell Foundation, approximately 4% of the global
population is affected by one of more than 80 different autoimmune diseases. Moreover,
the high consumption of tobacco and sedentary lifestyles are also responsible
for the growing hair loss among people.
New trends in treatment
methods, such as robotic hair restoration system and stem cell hair transplant,
are anticipated to positively impact this market’s growth and create affluent
opportunities for the hair loss treatment market. The growing awareness among
people regarding new treatment methods, increasing disposable income, and strong
marketing by companies are fueling the market growth.
The market can be negatively affected due to the risk of infection or side effects and also the high cost of medical treatment, such as hair transplant techniques. The risk of infection at the surgical site after hair transplant surgery builds fear in the patient from seeking treatment. Fear regarding side effects of medications like finasteride, such as skin rash, ejaculation disorder, and risk of prostate cancer, also hinder the market growth.
Key
geographies covered in the global hair loss treatment market are:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy,
Russia, and Rest of Europe
• Asia-Pacific: China, Japan, India, Australia & New
Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: Saudi Arabia, Turkey, United Arab
Emirates, South Africa, and Rest of Middle East & Africa
The
segmentation analysis of the hair loss treatment market includes:
• Gender Segment Includes:
O Female
O Male
• Indication Segment Includes:
O Androgenic Alopecia
O Alopecia Areata
O Alopecia Totalis
O Other Indications
• Treatment Type Segment Includes:
O Topical Treatment
• Minoxidil
• Shampoos
O Oral Treatment
• Finasteride
• Other Oral Hair Loss Treatment
O Other Treatment Types
• Sales Channel Segment Includes:
O Drug Stores & Retail Pharmacies
O Hospital Pharmacies
O Online Pharmacies
The hair loss treatment market
has a huge number of vendors, including the large established companies and the
booming startups continuously competing with each other. The key players
include Taisho Pharmaceutical Co Ltd, Johnson & Johnson, Transitions Hair
Pvt Ltd, Sun Pharmaceutical Industries Ltd, Merck & Co, Dr Reddys
Laboratories, Shiseido Company Limited, Cellmid, Daiichi Sankyo, Lexington
International Llc, Concert Pharmaceuticals Inc, Aclaris Therapeutics, The
Himalaya Drug Company, Cipla Limited, and Teva Pharmaceuticals.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
HAIR LOSS TREATMENT MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. EFFORTS
TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD
2.2.2. DEVELOPMENT
OF ROBOT HAIR RESTORATION SYSTEM
2.2.3. INTENSIVE
RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. CONTRACTS
& AGREEMENTS
2.6.4. INVESTMENT
& EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN CASES OF AUTOIMMUNE DISEASE
2.7.2. HIGH
CONSUMPTION OF ALCOHOL AND TOBACCO
2.7.3. UNHEALTHY
DIETARY HABITS
2.7.4. STRESS
AND CHANGING LIFESTYLES
2.8. MARKET
CHALLENGES
2.8.1. RISK
OF INFECTION OR SIDE EFFECTS
2.8.2. HIGH
COST OF TREATMENT
2.9. MARKET
OPPORTUNITIES
2.9.1. R&D
IN HAIR CLONING TECHNOLOGY
2.9.2. DEVELOPMENT
OF BARICITINIB
3. GLOBAL
HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER
3.1. FEMALE
3.2. MALE
4. GLOBAL
HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS
4.1. ANDROGENIC
ALOPECIA
4.2. ALOPECIA
AREATA
4.3. ALOPECIA
TOTALIS
4.4. OTHER
INDICATIONS
5. GLOBAL
HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE
5.1. TOPICAL
HAIR LOSS TREATMENT
5.1.1. MINOXIDIL
5.1.2. SHAMPOOS
5.2. ORAL
HAIR LOSS TREATMENT
5.2.1. FINASTERIDE
5.2.2. OTHER
ORAL HAIR LOSS TREATMENT
5.3. OTHER
TREATMENT TYPES
6. GLOBAL
HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL
6.1. DRUG STORES
& RETAIL PHARMACIES
6.2. HOSPITAL
PHARMACIES
6.3. ONLINE
PHARMACIES
7. GLOBAL
HAIR LOSS TREATMENT MARKET – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY GENDER
7.1.2. MARKET
BY INDICATION
7.1.3. MARKET
BY TREATMENT TYPE
7.1.3.1. MARKET
BY TOPICAL (TREATMENT) TYPE
7.1.3.2. MARKET
BY ORAL (TREATMENT) TYPE
7.1.4. MARKET
BY SALES CHANNEL
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY GENDER
7.2.2. MARKET
BY INDICATION
7.2.3. MARKET
BY TREATMENT TYPE
7.2.3.1. MARKET
BY TOPICAL (TREATMENT) TYPE
7.2.3.2. MARKET
BY ORAL (TREATMENT) TYPE
7.2.4. MARKET
BY SALES CHANNEL
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. RUSSIA
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY GENDER
7.3.2. MARKET
BY INDICATION
7.3.3. MARKET
BY TREATMENT TYPE
7.3.3.1. MARKET
BY TOPICAL (TREATMENT) TYPE
7.3.3.2. MARKET
BY ORAL (TREATMENT) TYPE
7.3.4. MARKET
BY SALES CHANNEL
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH
KOREA
7.3.5.5. ASEAN
COUNTRIES
7.3.5.6. AUSTRALIA
& NEW ZEALAND
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY GENDER
7.4.2. MARKET
BY INDICATION
7.4.3. MARKET
BY TREATMENT TYPE
7.4.3.1. MARKET
BY TOPICAL (TREATMENT) TYPE
7.4.3.2. MARKET
BY ORAL (TREATMENT) TYPE
7.4.4. MARKET
BY SALES CHANNEL
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY GENDER
7.5.2. MARKET
BY INDICATION
7.5.3. MARKET
BY TREATMENT TYPE
7.5.3.1. MARKET
BY TOPICAL (TREATMENT) TYPE
7.5.3.2. MARKET
BY ORAL (TREATMENT) TYPE
7.5.4. MARKET
BY SALES CHANNEL
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.2. SAUDI
ARABIA
7.5.5.3. TURKEY
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. TEVA
PHARMACEUTICALS
8.2. MERCK
& CO
8.3. CIPLA
LIMITED
8.4. JOHNSON
& JOHNSON
8.5. SUN
PHARMACEUTICAL INDUSTRIES LTD
8.6. CONCERT
PHARMACEUTICALS INC
8.7. SHISEIDO
COMPANY LIMITED
8.8. TAISHO
PHARMACEUTICAL CO LTD
8.9. DR
REDDYS LABORATORIES
8.10. THE
HIMALAYA DRUG COMPANY
8.11. TRANSITIONS
HAIR PVT LTD
8.12. LEXINGTON
INTERNATIONAL LLC
8.13. ACLARIS
THERAPEUTICS
8.14. CELLMID
8.15. DAIICHI
SANKYO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL HAIR LOSS
TREATMENT MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: LIST OF INVESTMENT
& EXPANSIONS
TABLE 7: GLOBAL HAIR LOSS
TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL HAIR LOSS
TREATMENT MARKET, BY INDICATIONS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL HAIR LOSS
TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL HAIR LOSS
TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL HAIR LOSS
TREATMENT MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA HAIR LOSS
TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE HAIR LOSS
TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE HAIR LOSS
TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 23: EUROPE HAIR LOSS
TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 24: EUROPE HAIR LOSS
TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: EUROPE HAIR LOSS
TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 26: EUROPE HAIR LOSS
TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 27: EUROPE HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 35: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $
MILLION)
TABLE 47: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS
INDEX
FIGURE 2: PREVALENCE OF
DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019
FIGURE 3: GLOBAL HAIR LOSS
TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 4: GLOBAL HAIR LOSS
TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL HAIR LOSS
TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL HAIR LOSS
TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)
FIGURE 7: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL HAIR LOSS
TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL HAIR LOSS
TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)
FIGURE 12: GLOBAL HAIR LOSS
TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 13: GLOBAL HAIR LOSS
TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL HAIR LOSS
TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL HAIR LOSS
TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 17: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL HAIR LOSS
TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL HAIR LOSS
TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL HAIR LOSS
TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)
FIGURE 22: GLOBAL HAIR LOSS
TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL HAIR LOSS
TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL HAIR LOSS
TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL HAIR LOSS
TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: UNITED STATES HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: CANADA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: UNITED KINGDOM HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: GERMANY HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: FRANCE HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: SPAIN HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: ITALY HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: RUSSIA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: REST OF EUROPE HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: CHINA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: JAPAN HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: INDIA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: SOUTH KOREA HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: ASEAN COUNTRIES
HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW
ZEALAND HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF
ASIA-PACIFIC HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: BRAZIL HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: MEXICO HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: REST OF LATIN
AMERICA HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: UNITED ARAB
EMIRATES HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: SAUDI ARABIA HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: TURKEY HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: SOUTH AFRICA HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 49: REST OF MIDDLE EAST
& AFRICA HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)